Vaccination, Haemophilus influenzae type B (HIB)
Immunization designed to prevent diseases caused by Haemophilus influenzae type B (HIB), a bacteria responsible for a range of serious “invasive” diseases including meningitis with potential brain damage and epiglottitis with airway obstruction.
More than 90% of all HIB infections occur in children 5 years of age or less; the peak attack rate is at 6-12 months of age.
The HIB vaccine is usually given at 2, 4 and 6 months of age and a final booster is given at 12-15 months of age. HIB vaccine rarely causes severe reactions. The HIB vaccine has almost eradicated the disease. Before the vaccine, some 20,000 cases of HIB invasive disease in preschool children were reported every year in the U.S. compared to less than 300 cases after the advent of the vaccine.
The HIB vaccine is a “conjugate” vaccine. It joins (“conjugates”) sugars from the HIB bacteria with a protein from another bacteria. The protein stimulates the baby’s immature immune cells so they produce antibodies to the HIB sugars, protecting the child from HIB infection.
The prestigious Albert Lasker Award for Clinical Medical Research was given in 1996 to David H. Smith, Porter W. Anderson Jr., John B. Robbins and Rachel Schneerson for their work in developing a vaccine against Haemophilus influenzae type B.
Read Also:
- Vaccination, hepatitis B
Hepatitis B (hep B) vaccine gives prolonged protection, but 3 shots over a half year are usually required. All infants in the U.S. receive hep B vaccine. Two vaccines (Engerix-B, and Recombivax-HB) are available in the US. The first dose of hep B vaccine is frequently given while the newborn is in the hospital or […]
- Vaccination, HIB
This immunization is designed to prevent diseases caused by Haemophilus influenzae type B (HIB), a bacteria responsible for a range of serious “invasive” diseases including meningitis with potential brain damage and epiglottitis with airway obstruction. More than 90% of all HIB infections occur in children 5 years of age or less; the peak attack rate […]
- Vaccination, infectious hepatitis
See Immunization, hepatitis A.
- Vaccination, pneumococcal pneumonia
This vaccine, which prevents one of the most common and severe forms of pneumonia, is usually given only once in a lifetime, usually after the age of 55, to someone with ongoing lung problems (such as chronic obstructive pulmonary disease (COPD) or asthma) or other chronic diseases (including those involving the heart and kidneys). This […]
- Vaccination, polio
The vaccines available for vaccination against polio are OPV (Oral Polio Vaccine) and IPV (Inactivated Polio Vaccine). OPV is still the preferred vaccine for most children. As its name suggests, it is given by mouth. IPV, or Inactivated Polio Vaccine is given as a shot in the arm or leg. Infants and children should be […]